Parihar J, Glaucoma. The ‘Black hole’of irreversible blindness. Med J Armed Forces India. 2016;72(1):3.
Article CAS PubMed PubMed Central Google Scholar
Kingman S. Glaucoma is the second leading cause of blindness globally. Bull World Health Organ. 2004;82:887–8.
PubMed PubMed Central Google Scholar
Kapetanakis VV, Chan MP, Foster PJ, Cook DG, Owen CG, Rudnicka AR. Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis. Br J Ophthalmol. 2015.
Tham Y-C, Li X, Wong TY, Quigley HA, Aung T, Cheng C-Y. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081–90.
Kyari F, Adekoya B, Abdull MM, Mohammed AS, Garba F. The current status of glaucoma and glaucoma care in sub-saharan Africa. Asia-Pacific J Ophthalmol. 2018;7(6):375–86.
Abdull MM, Gilbert CC, Evans J. Primary open angle glaucoma in northern Nigeria: stage at presentation and acceptance of treatment. BMC Ophthalmol. 2015;15:1–8.
Chauke GD, Nakwafila O, Chibi B, Sartorius B, Mashamba-Thompson T. Factors influencing poor medication adherence amongst patients with chronic disease in low-and-middle-income countries: a systematic scoping review. Heliyon. 2022.
Adekoya B, Adepoju F, Moshood K, Balarabe AH. Challenges in the management of glaucoma in a developing country; a qualitative study of providers’ perspectives. Niger J Med. 2015;24(4):315–22.
Article CAS PubMed Google Scholar
Sleath B, Blalock SJ, Covert D, Skinner AC, Muir KW, Robin AL. Patient race, reported problems in using glaucoma medications, and adherence. International Scholarly Research Notices. 2012;2012.
Feehan M, Munger MA, Cooper DK, Hess KT, Durante R, Jones GJ, et al. Adherence to glaucoma medications over 12 months in two US community pharmacy chains. J Clin Med. 2016;5(9):79.
Article PubMed PubMed Central Google Scholar
Kim CY, Park KH, Ahn J, Ahn M-D, Cha SC, Kim HS et al. Treatment patterns and medication adherence of patients with glaucoma in South Korea. Br J Ophthalmol. 2017.
Driessen S, Nelson-Ayifah D, Ampong A, Klaver CC, Bonnemaijer PW, Thiadens AA. Risk factors for compliance to medication in African glaucoma patients. Investig Ophthalmol Vis Sci. 2022;63(7):1636–A0131. -1636–A0131.
Bello SI, Ojieabu WA, Yusuf H. Drug utilization, medication adherence and treatment satisfaction amongst glaucoma patients receiving care at secondary health facilities. J Pharm Health Serv Res. 2023;14(1):71–8.
Melaku MW, Yibekal BT, Demilew KZ. Adherence to topical anti-glaucoma medications in Sidama regional state, Southern Ethiopia. PLoS ONE. 2023;18(4):e0284200.
Article CAS PubMed PubMed Central Google Scholar
Anbesse DH, Yibekal BT, Assefa NL. Adherence to topical glaucoma medications and associated factors in Gondar University Hospital Tertiary Eye Care Center, northwest Ethiopia. Eur J Ophthalmol. 2019;29(2):189–95.
Assem AS, Fekadu SA, Yigzaw AA, Nigussie ZM, Achamyeleh AA. Level of glaucoma drug adherence and its associated factors among adult glaucoma patients attending felege hiwot specialized hospital, Bahir Dar City, Northwest Ethiopia. Clinical optometry. 2020:189 – 97.
Tamrat L, Gessesse GW, Gelaw Y. Adherence to topical glaucoma medications in Ethiopian patients. Middle East Afr J Ophthalmol. 2015;22(1):59.
Article PubMed PubMed Central Google Scholar
Newman-Casey PA, Robin AL, Blachley T, Farris K, Heisler M, Resnicow K, et al. The most common barriers to glaucoma medication adherence: a cross-sectional survey. Ophthalmology. 2015;122(7):1308–16.
Gatwood J, Brooks C, Meacham R, Abou-Rahma J, Cernasev A, Brown E, et al. Facilitators and barriers to glaucoma medication adherence. J Glaucoma. 2022;31(1):31–6.
Sleath BL, Blalock SJ, Muir KW, Carpenter DM, Lawrence SD, Giangiacomo AL, et al. Determinants of self-reported barriers to glaucoma medicine administration and adherence: a multisite study. Ann Pharmacother. 2014;48(7):856–62.
Muir KW, Rosdahl JA, Hein AM, Woolson S, Olsen MK, Kirshner M, et al. Improved glaucoma medication adherence in a randomized controlled trial. Ophthalmol Glaucoma. 2022;5(1):40–6.
Taylor SA, Galbraith SM, Mills RP. Causes of non-compliance with drug regimens in glaucoma patients: a qualitative study. J Ocul Pharmacol Ther. 2002;18(5):401–9.
Article CAS PubMed Google Scholar
Tsai JC, McClure CA, Ramos SE, Schlundt DG, Pichert JW. Compliance barriers in glaucoma: a systematic classification. J Glaucoma. 2003;12(5):393–8.
Friedman DS, Hahn SR, Gelb L, Tan J, Shah SN, Kim EE, et al. Doctor–patient communication, health-related beliefs, and adherence in glaucoma: results from the glaucoma adherence and persistency study. Ophthalmology. 2008;115(8):1320–7. e3.
Martin BC, Wiley-Exley EK, Richards S, Domino ME, Carey TS, Sleath BL. Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication. Ann Pharmacother. 2009;43(1):36–44.
Ngozi oNwubikoA S, zuada NwachukwuA N. Glaucoma medications: issues with adherence in a tertiary hospital in Nigeria. Family Med Prim Care Rev. 2020;22(4):302–6.
Munir H, Sadiq M, Khan S, Zafar S, Akhtar F. Factors Associated with Non-compliance to Long term Glaucoma medication in a developing country. Pakistan J Ophthalmol. 2022;38(3).
Khandekar R, Shama ME-S, Mohammed AJ. Noncompliance with medical treatment among glaucoma patients in Oman—a cross-sectional descriptive study. Ophthalmic Epidemiol. 2005;12(5):303–9.
Mc Clelland JF, Bodle L, Little J-A. Investigation of medication adherence and reasons for poor adherence in patients on long-term glaucoma treatment regimes. Patient Prefer Adherence. 2019:431–9.
Costa Andrade J, Motta GS, Kasahara N. Perspectives on adherence to Glaucoma medical therapy in Brazilian patients. Pharm Med. 2023:1–8.
留言 (0)